Company news

Famicord Ag (XETR:V3V) news

Famicord Ag news releases on 6ix. Latest, Sep 24, 2026: FamiCord AG wins promising new client for its CDMO activities with manufacturing agreement for pivotal…

View Famicord Ag →

Press releases & updates

FamiCord AG wins promising new client for its CDMO activities with manufacturing agreement for pivotal Phase II/III trial with initial value in the low single-digit millions of euros

September 24, 2026

FamiCord significantly improves operating cash flow in Q2 2026 amid persistently challenging business environment

August 28, 2026

FamiCord AG to transfer to the Scale segment effective 19 August 2026

August 18, 2026

Management Board of FamiCord AG resolves on intended transfer of stock exchange listing from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange

June 29, 2026

FamiCord AG wins ArThec as another customer in its CDMO business area

June 23, 2026

FamiCord AG records weaker start to 2026 financial year as expected amid continued market headwinds while subscription base remains robust

May 29, 2026

FamiCord AG closes financial year 2025 with overall solid year-end business while preparing for increasing macroeconomic and political headwinds

April 30, 2026

FamiCord AG publishes preliminary figures for 2025 and outlook for 2026

April 15, 2026

FamiCord AG accelerates profitable growth in the third quarter of 2025 and further strengthens quality and visibility of revenues

November 21, 2025

FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. is to acquire 100 % in stem cell bank “nOvum” spółka z ograniczoną odpowiedzialnością, Warsaw, Poland

September 16, 2025

FamiCord : The first method for expanding umbilical cord blood stem cells has received authorization from the European Commission

September 10, 2025

FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future

August 27, 2025

FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek

May 28, 2025

FamiCord AG starts 2025 financial year with accelerated growth and increases profitability at almost all earnings levels

May 28, 2025

FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany

April 30, 2025

FamiCord AG significantly exceeds annual earnings guidance for 2024 on the basis of preliminary figures

April 10, 2025